Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1307 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Incretin response in Asian type 2 diabetes: Are Indians different?

Singh Awadhesh Kumar

Year : 2015| Volume: 19| Issue : 1 | Page no: 30-38

   This article has been cited by
1 Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin
Katsuya Shibuki,Shuji Shimada,Takao Aoyama,Daniela Foti
Journal of Diabetes Research. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
2 South Asians with type 2 diabetes in an urban US Diabetes Center: A cross sectional study of clinical characteristics
Wedad Rahman,Amiya Ahmed,Silpa Poola-Kella,Kashif M. Munir
Obesity Medicine. 2020; 19: 100267
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Sushrima Gan,Adem Y. Dawed,Louise A. Donnelly,Anand T.N. Nair,Colin N.A. Palmer,Viswanathan Mohan,Ewan R. Pearson
Diabetes Care. 2020; 43(8): 1948
[Pubmed]  [Google Scholar] [DOI]
4 An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors
Elizabeth Mary Lamos,Maka Hedrington,Stephen N Davis
Expert Opinion on Drug Safety. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka
Devarajan Rathish,Channa Jayasumana,Suneth Agampodi
Journal of Health, Population and Nutrition. 2019; 38(1)
[Pubmed]  [Google Scholar] [DOI]
6 Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association
Annabelle Santos Volgman,Latha S. Palaniappan,Neelum T. Aggarwal,Milan Gupta,Abha Khandelwal,Aruna V. Krishnan,Judith H. Lichtman,Laxmi S. Mehta,Hena N. Patel,Kevin S. Shah,Svati H. Shah,Karol E. Watson
Circulation. 2018; 138(1)
[Pubmed]  [Google Scholar] [DOI]
7 Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males
Ganesh V. Sangle,Mohan Patil,Nitin J. Deshmukh,Sushant A. Shengule,Shantibhushan Kamble,Kiran Kumar Vuppalavanchu,Sushil Kale,Mirza Layeeq Ahmed Baig,Geetchandra Singh,Javed Shaikh,Jitendra Tripathi,P. Aravindababu
European Journal of Clinical Pharmacology. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
Yu Mi Kang,Yun Kyung Cho,Jiwoo Lee,Seung Eun Lee,Woo Je Lee,Joong-Yeol Park,Ye-Jee Kim,Chang Hee Jung,Michael A. Nauck
Diabetes & Metabolism Journal. 2018; 42
[Pubmed]  [Google Scholar] [DOI]
9 A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka
Devarajan Rathish,Indika Senavirathna,Channa Jayasumana,Suneth Agampodi,Sisira Siribaddana
Environmental Science and Pollution Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Ethnic Difference in the Pharmacodynamics-efficacy Relationship of Dipeptidyl Peptidase-4 Inhibitors Between Japanese and non-Japanese Patients: A Systematic Review
Y Ito,K Ambe,M Kobayashi,M Tohkin
Clinical Pharmacology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies
Plamen Kozlovski,Marilia Fonseca,Viswanathan Mohan,Valentina Lukashevich,Masato Odawara,Päivi M. Paldánius,Wolfgang Kothny
Diabetes, Obesity and Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]
12 From organophosphate poisoning to diabetes mellitus: The incretin effect
D. Rathish,S.B. Agampodi,M.A.C.S. Jayasumana,S.H. Siribaddana
Medical Hypotheses. 2016; 91: 53
[Pubmed]  [Google Scholar] [DOI]
13 Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions
Kayo Fujita,Masayuki Kaneko,Mamoru Narukawa
Clinical Drug Investigation. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?
Ernesto Maddaloni,Luca DćOnofrio,Paolo Pozzilli
Diabetes/Metabolism Research and Reviews. 2016; 32(2): 169
[Pubmed]  [Google Scholar] [DOI]
15 Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Naveed Sattar,Jason M R Gill
The Lancet Diabetes & Endocrinology. 2015; 3(12): 1004
[Pubmed]  [Google Scholar] [DOI]


Read this article